Skip to content
10-Q

Quarterly Report

PALOMINO LABORATORIES INC. PALX

0001493152-26-023678

← back to feed
Filed
May 15, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 15, 2026 23.16M sh
Shares Diluted Q1 2026 · Mar 31, 2026 18.51M sh
Shares Diluted restated Q1 2026 · Mar 31, 2025 2.23M sh
Capex Q1 2026 · Mar 31, 2026 $318.34K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$1.12M
Operating Cash Flow restated Q1 2026 · Mar 31, 2025 $3.05K
Cash And Equivalents Q1 2026 · Mar 31, 2026 $6.66M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $8.12M
Stockholders Equity Q1 2026 · Mar 31, 2026 $7.01M
Stockholders Equity Q1 2026 · Dec 31, 2025 $8.1M
Stockholders Equity restated Q1 2026 · Mar 31, 2025 −$991.65K
Stockholders Equity restated Q1 2026 · Dec 31, 2024 −$18.31K
Stockholders Equity restated Q1 2026 · Dec 31, 2023 −$18.31K
Current Liabilities Q1 2026 · Mar 31, 2026 $228.86K
Current Liabilities Q1 2026 · Dec 31, 2025 $336.46K
Total Liabilities Q1 2026 · Mar 31, 2026 $351.97K
Total Liabilities Q1 2026 · Dec 31, 2025 $336.46K
Current Assets Q1 2026 · Mar 31, 2026 $6.83M
Current Assets Q1 2026 · Dec 31, 2025 $8.43M
Total Assets Q1 2026 · Mar 31, 2026 $7.36M
Total Assets Q1 2026 · Dec 31, 2025 $8.43M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.07
Eps Diluted restated Q1 2026 · Mar 31, 2025 −$0.44
Eps Basic Q1 2026 · Mar 31, 2026 −$0.07
Eps Basic restated Q1 2026 · Mar 31, 2025 −$0.44
Sga Expense Q1 2026 · Mar 31, 2026 $805.36K
Sga Expense restated Q1 2026 · Mar 31, 2025 $17.83K
Rd Expense Q1 2026 · Mar 31, 2026 $438.24K
Net Income Q1 2026 · Mar 31, 2026 −$1.24M
Net Income restated Q1 2026 · Mar 31, 2025 −$985.17K
Operating Income Q1 2026 · Mar 31, 2026 −$1.24M
Operating Income restated Q1 2026 · Mar 31, 2025 −$17.83K